The LigaSure™ small jaw instrument (LF1212A), working exclusively with the ForceTriad™ energy platform, combines TissueFect™ sensing technology with hand or foot activation and an integrated cutting mechanism to create a multifunctional tissue sealing system that provides consistent, controlled tissue effect.
This instrument is designed for use in open procedures. Procedural applications include([FOOTNOTE=For the full list of indications, please refer to the product IFU.],[ANCHOR=],[LINK=]):
|
|
The LigaSure™ small jaw instrument is an 18.8 cm (7.4 inch) vessel sealer and divider, designed to be used in confined surgical spaces where access and visibility are a necessity. The instrument has a low temperature profile and seals effectively at a cooler temperature compared to Harmonic FOCUS™*([FOOTNOTE=When compared to the Harmonic FOCUS™* as part of an August 3, 2010, study comparing device temperatures during seal tests on porcine tissue either in-vivo or freshly excised. (Covidien test report R0021935B dated September 14, 2012.)],[ANCHOR=],[LINK=]).
The LigaSure™ small jaw instrument:
LigaSure™ technology confines effect to target tissue with thermal spread ≤ 2mm on average, so you can feel more confident sealing near critical structures and dissecting around vessels.
Ligasure™ technology has been shown to significantly reduce hospital stay and post-operative drainage days compared to conventional techniques when used for axillary breast dissection.([FOOTNOTE=Cortadellas-Rosel T, Córdoba-Cardona O, Espinosa-Bravo M, Mendoza-Santin C, Rodríguez-Fernández J, Esgueva-Colmenarejo A, Alvarez-Vinuesa M, Rubio-Rodríguez IT, Xercavins-Montosa J. Electrothermal bipolar vessel sealing system in axillary dissection: A prospective randomized clinical study. Int J Surg. 2011 Sep 10.],[ANCHOR=],[LINK=]) Additionally, LigaSure™ instruments may be associated with:
Across the range of products and procedures, LigaSure™ technology delivers a unique combination of pressure and energy to create a consistent seal with each application.
TissueFect™ sensing technology is the control system for the ForceTriad™ energy platform, designed to precisely manage energy delivery, creating a range of options for desired tissue effect. TissueFect™ sensing technology monitors changes in tissue impedance 3,333 times a second, and adjusts energy output accordingly to deliver the appropriate amount of energy for the desired tissue effect.
LigaSure™ vessel sealing technology has been updated and improved in the ForceTriad™ energy platform, controlled by TissueFect™ sensing technology. LigaSure™ tissue fusion, like LigaSure™ vessel sealing, uses the body’s own collagen and elastin to create a permanent fusion zone. This technology can fuse vessels up to and including 7 mm, lymphatics, tissue bundles and pulmonary vasculature, and has an average seal cycle of two to four seconds in most surgical situations.